ArticleThe New England journal of medicine2014
A new hope for idiopathic pulmonary fibrosis.
Article in The New England journal of medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Comparing new treatments for idiopathic pulmonary fibrosis--a network meta-analysis.BMC pulmonary medicine · 2015Pooled it
- Mice carrying the homologous human shelterin POT1-L259S mutation linked to pulmonary fibrosis show a telomerase deficiency-like phenotype with telomere shortening with increasing mouse generations.Genes & development · 2025Article
- LTI-03 peptide demonstrates anti-fibrotic activity iniScience · 2025Article
- Pulmonary Surface Irregularity Score as a New Quantitative CT Marker for Idiopathic Pulmonary Fibrosis-a Pilot Study.Journal of digital imaging · 2023Article
- Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative.Chest · 2022Review
- Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging.The Journal of cell biology · 2020Article
- Article
- Effects of New NSAID-CAI Hybrid Compounds in Inflammation and Lung Fibrosis.Biomolecules · 2020Article
- Idiopathic pulmonary fibrosis: pathogenesis and management.Respiratory research · 2018Review
- Article
- Thin-section computed tomography-determined usual interstitial pneumonia pattern affects the decision-making process for resection in newly diagnosed lung cancer patients: a retrospective study.BMC pulmonary medicine · 2018Article
- Discovery of Indolinone-Based Multikinase Inhibitors as Potential Therapeutics for Idiopathic Pulmonary Fibrosis.ACS medicinal chemistry letters · 2017Article
- Idiopathic Pulmonary Fibrosis: Data-driven Textural Analysis of Extent of Fibrosis at Baseline and 15-Month Follow-up.Radiology · 2017Article
- Unifying mechanism for different fibrotic diseases.Proceedings of the National Academy of Sciences of the United States of America · 2017Article
- HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.Journal of cellular and molecular medicine · 2017Article
- 3D pulmospheres serve as a personalized and predictive multicellular model for assessment of antifibrotic drugs.JCI insight · 2017Article
- Spermidine-mediated poly(lactic-International journal of nanomedicine · 2017Article
- Idiopathic pulmonary fibrosis: Physicians' perceptions of patient treatment with recently approved drugs.Contemporary clinical trials communications · 2016Article
- Autophagy: Friend or Foe in Lung Disease?Annals of the American Thoracic Society · 2016Review
- Article
Corrections and comments
- Comment on
- Comment on
Authors and funding
1 author.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
24836311What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.